Quick Answer
Processa Pharmaceuticals, Inc. reported Total Assets of $7.81 million for fiscal year 2025.
Processa Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.81M | +142.0% |
| 2024 | $3.23M | -44.2% |
| 2023 | $5.79M | -32.9% |
| 2022 | $8.62M | -67.4% |
| 2021 | $26.46M | +5.0% |
| 2020 | $25.21M | +131.7% |
| 2019 | $10.88M | -12.8% |
| 2018 | $12.48M | +318.4% |
| 2017 | $2.98M | +26.1% |
| 2016 | $2.36M | +2167.0% |
| 2015 | $104.3K | -95.9% |
| 2014 | $2.55M | -13.3% |
| 2013 | $2.94M | -24.4% |
| 2012 | $3.88M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.58M | +53.5% | -7.3% |
| June 30, 2025 | $8.18M | +7.6% | +70.1% |
| March 31, 2025 | $4.81M | -51.6% | +48.9% |
| December 31, 2024 | $3.23M | -44.2% | -34.7% |
| September 30, 2024 | $4.94M | -38.9% | -35.0% |
| June 30, 2024 | $7.60M | -24.7% | -23.6% |
| March 31, 2024 | $9.94M | -20.0% | +71.9% |
| December 31, 2023 | $5.79M | -32.9% | -28.4% |
- Processa Pharmaceuticals, Inc. showed an increase of +142.0% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Processa Pharmaceuticals, Inc.’s total assets has grown by 101.2% (from $3.88 million to $7.81 million).
- The most recent figure is from Processa Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: